Andrielly H.R. Agnellini

Author

Also Known As

Andrielly Agnellini, Andrielly H. R. Agnellini, Andrielly H.R. Agnellini, Andrielly HR Agnellini, Andrielly H.R. Agnellini

Publications

571

Citations

H-Index

Concepts

All Affiliations

Andrielly H.R. Agnellini is an author at University of Padua specializing in medicine, immunology, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	442
2	Cell Biology	3	3	388
3	Immunology	3	3	267
4	Pharmacology	1	1	54
5	Autoimmune Disease	1	1	54

Andrielly H.R. Agnellini

Publications

517

Citations

H-Index

Page 1

	Year	Citations
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells Ilaria Marigo, Serena Zilio, Giacomo Desantis, Cancer Cell InflammationTumor Necrosis FactorCancer ImmunosurveillanceT-regulatory CellImmunology	2016	199
Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1 Stéphanie Herkenne, Olivier Ek, Margherita Zamberlan, Cell Metabolism Developmental BiologyAngiogenesisMedicineCell BiologyTumor Microenvironment	2020	175
Targeting monoamine oxidase to dampen NLRP3 inflammasome activation in inflammation Ricardo Sánchez‐Rodríguez, Fabio Munari, Roberta Angioni, Cellular and Molecular Immunology InflammationAnti-inflammatoryAutoimmune DiseaseMedicineImmunology	2020	54
OPA1 drives macrophage metabolism and functional commitment via p65 signaling Ricardo Sánchez‐Rodríguez, Caterina Tezze, Andrielly H.R. Agnellini, Cell Death and Differentiation	2022	44
Critical role of gap junction communication, calcium and nitric oxide signaling in bystander responses to focal photodynamic injury Bianca Calì, Stefano Ceolin, Federico Ceriani, Oncotarget	2015	31
GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors Bianca Calì, Andrielly H.R. Agnellini, Chiara Cioccarelli, Frontiers in Immunology ImmunologyImmunotherapyReactive Oxygen SpeciesTumor BiologyMyeloid Neoplasia	2021	14

Page 1